GE HealthCare
GEHC
38 hedge funds and large institutions have $852M invested in GE HealthCare in 2022 Q4 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
28% less call options, than puts
Call options by funds: $6.83M | Put options by funds: $9.49M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$373M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$366M |
| 3 |
GCM
Gates Capital Management
New York
|
+$43.5M |
| 4 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
+$12.2M |
| 5 |
Millennium Management
New York
|
+$6.25M |
Top Sellers
GEHC Hedge Fund Activity: Q4 2022 in Review
38 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in GE HealthCare (GEHC) for Q4 2022, worth a combined $852M.
Buyers outnumbered sellers: 38 funds opened new GEHC positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $373M.
- 38 institutional investors held GE HealthCare (GEHC) as of Q4 2022, up from 0 in Q3 2022.
- Funds reported $852M of GE HealthCare stock for Q4 2022.
- 38 funds opened new GE HealthCare positions in Q4 2022 and 0 closed out, a net change of +38 holders.
- The largest GE HealthCare buyer in Q4 2022 was T. Rowe Price Investment Management, an estimated $373M added.
Based on aggregated 13F filings for Q4 2022.